Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of European American background who have DNA samples available and have been identified as either a "case" or "control" participant for this study
- People who developed severe high blood pressure (graded 3 or 4 out of 4 in severity) as a side effect while being treated with a medicine called bevacizumab
- People who completed a full course of treatment with bevacizumab and did not develop high blood pressure during that time
Who may not be able to join:
- No specific exclusion criteria were listed in the official trial information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of rare coding variants of large effect that predict the risk of bevacizumab-induced hypertension
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.